Engraftable Cell-Based Immunotherapy for Long-Term Delivery of Therapeutic Proteins
Copyright © Targeted News Service 2024
2024-03-26
ALEXANDRIA, Virginia, March 26 -- SEATTLE CHILDREN'S HOSPITAL, Seattle, Washington has been assigned a patent (No. US 11939594 B2, initially filed March 14, 2018) developed by six inventors David J. Rawlings, Seattle, Washington; Richard James, Seattle, Washington; Shaun W. Jackson, Seattle, Washington; Iram Khan, Issaquah, Washington; King Hung, Seattle, Washington; and Andrew M. Scharenberg, Seattle, Washington, for "Engraftable cell-based immunotherapy for long-term delivery of therapeutic p . . .